On 15 April 2014
AstraZeneca Pharma India will hold a meeting of the Board of Directors of the Company on 15 April 2014, inter alia, to consider seeking approval of shareholders of the Company through Postal Ballot, for the voluntary delisting proposed by AstraZeneca Pharmaceuticals AB Sweden, promoter of the Company, in terms of Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009.Powered by Capital Market - Live News
